PRECISIONBIOLOGICS
Menu
↗
Regulatory

What not to claim in stem cell marketing

Plain-language list of claim types clinics should avoid when advertising perinatal biologics or stem cell search terms.

Reviewed 2026-10-27

Claims to avoid

Do not claim cures, treatment of named diseases, guaranteed results, or live-cell content that is not documented.

Search demand for stem cell does not justify using that phrase as a product attribute.

Safer professional framing

Describe documentation, account eligibility, and product identity. Send intended-use questions to counsel.

Use not a stem cell therapy framing where stem-cell-adjacent terms appear.

Platform and policy constraints

Ad platforms often restrict regenerative and stem cell claims. Review creatives before spend.

If ads avoid disease claims, landing pages must avoid them too.

Operational checklist for stem cell marketing claims to avoid

Before ordering under the topic stem cell marketing claims to avoid, confirm storage class, receiving owner, and which documents will be required at release.

Close open items in writing. Do not infer missing COA fields from a different lot or SKU.

FAQ

Frequently asked questions

Does Precision Biologics certify regulatory status for our use?+

No. Classification and intended-use determinations belong to the ordering physician and clinic counsel.

Is this legal advice?+

No. This is general information for licensed healthcare professionals.

Can account approval replace counsel review?+

No. Account verification is administrative only.

Does this page determine how we may use products discussed under stem cell marketing claims to avoid?+

No. Intended use remains with the ordering physician and clinic counsel.

Sources

  1. FDA: Minimal Manipulation and Homologous Use guidance ↗FDA
  2. 21 CFR Part 1271 ↗eCFR